NCT02223494View on ClinicalTrials.gov

Safety of Terbogrel in Patients With Primary Pulmonary Hypertension

PHASE2TerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

March 31, 2000

Conditions
Hypertension, Pulmonary
Interventions
DRUG

Terbogrel

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY